A novel polymorphism of the human CD40 receptor with enhanced function

Blood

Volumn 112, Issue 5, 2008, Pages 1863-1871

  Peters, Anna L ^a   Plenge, Robert M ^b   Graham, Robert R ^b   Altshuler, David M ^b   Moser, Kathy L ^c   Gaffney, Patrick M ^c   Bishop, Gail A ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; INTERLEUKIN 6; PROTEIN C JUN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; IL6 PROTEIN, HUMAN; RECOMBINANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 9;

ANTIGEN FUNCTION; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; AMINO ACID SUBSTITUTION; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; GENE FREQUENCY; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PHENOTYPE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CELL LINE; GENE FREQUENCY; HUMANS; IMMUNOGLOBULIN M; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; TRANSFECTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52649087201     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-138925     Document Type: Article

References (50)

1. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol. 2000;67:2-17.
2. Bishop GA, Hostager BS. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 2003;14:297-309.
3. Stout RD. Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today. 1996;17:487-492.
4. Fuleihan RL. The hyper IgM syndrome. CurrAllergy Asthma Rep. 2001;1445-450.
5. Lougaris V, Badolato R. Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev. 2005;203:48-66.
6. Gaffney PM, Langefeld CD. Graham RR, et al. Fine-mapping chromosome 20 in 230 systemic lupus erythematosus sib pair and multiplex families: evidence tor genetic epistasis with chromosome 16q12. Am J Hum Genet. 2006;78:747-758.
7. Thompson SD, Moroldo MB, Guyer L, et al. A genome-wide scan tor juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. Arthritis Rheum. 2004;50:2920-2930.
8. Tomer Y. Barbesino G, Greenberg DA. Concepcion E, Davies TF. A new Graves diseasesusceptibility locus maps to chromosome 20q11.2. International Consortium for the Genetics of Autoimmune Thyroid Disease. Am J Hum Genet. 1998;63:1749-1756.
9. Tomer Y Concepcion E. Greenberg DA. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid. 2002;12:1129-1135.
10. Kim TY, Park YJ, Hwang JK, et al. A C/T polymorphism in the 5'-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid. 2003;13:919-925.
11. Mukai T, Hiromatsu Y, Fukutani T et al. A C/T polymorphism in the 5' untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese. Endocr J. 2005:52: 471-477.
12. Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clin Endocrinol (Oxf). 2004:61:269-272.
13. Houston FA, Wilson V, Jennings CE, et al. Role of the CD40 locus in Graves' disease. Thyroid. 2004:14:506-509.
14. Chadha S, Miller K, Farwell L, et al. Haplotype structure of TN FRSF5-TN FSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur J Hum Genet. 2005:13:669-676.
15. Cann HM, de Toma C. Cazes L, et al. A human genome diversity cell line panel. Science. 2002; 296:261-262.
16. Krangel MS, Orr HT Strominger JL. Assembly and maturation of HLA-A and HLA-B antigens in vivo. Cell. 1979;18:979-991.
17. + B cells by clonal Tcells and antigen. Proc Natl Acad Sci U S A. 1986:83:7410-7414.
18. Hostager BS, Hsing Y, Harms DE, Bishop GA. Different CD40-mediated signaling events require distinct CD40 structural features. J Immunol. 1996;157:1047-1053.
19. Brown KD, Hostager BS, Bishop GA. Differential signaling and TRAF degradation by CD40 and the EBV oncoprotein LMP1. J Immunol. 2001: 193:943-954.
20. Hostager BS, Bishop GA. Role of TRAF2 in the activation of IgM secretion by CD40 and CD120b. J Immunol. 2002:168:3318-3322.
21. Baccam M, Bishop GA. Membrane-bound CD154, but not anti-CD40 rnAbs, induces NF-kB independent B cell IL-6 production. Eur J Immunol. 1999:29:3855-3866.
22. Stunz LL, Busch LK, Munroe ME, et al. Expression of the LMP1 cytoplasmic tail in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture. Immunity. 2004;21:255-266.
23. Hostager BS, Catlett IM, Bishop GA. Recruitment of CD40, TRAF2, and TRAF3 to membrane microdomains during CD40 signaling. J Biol Chem. 2000;275:15392-15398.
24. Krieg AM, Yi A-K, Matson S, et al. CpG motifs in bacterial DNA trigger direct B cell activation. Nature. 1995:374:546-550.
25. Haxhinasto SA, Hostager BS, Bishop GA. Cutting edge: molecular mechanisms of synergy between CD40 and the BCR: role for TRAF2 in receptor interaction. J Immunol. 2002:169:1145-1149.
26. Vanden Bush TJ, Bishop GA. TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation. Eur J Immunol. 2008:38: 400-409.
27. Xie P, Bishop GA. Roles of TRAF3 in signaling to B lymphocytes by CTAR regions 1 and 2 of the EBV-encoded oncoprotein LMP1. J Immunol. 2004:173:5546-5555.
28. Rosenberg NA, Pritchard JK, Weber JL, et al. Genetic structure of human populations. Science. 2002:298:2381-2385.
29. Bishop GA. The multifaceted roles of TRAFs in the regulation of B cell function. Nat Rev Immunol. 2004;4:775-786.
30. Baccam M, Woo SY, Vinson C, Bishop GA. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J Immunol. 2003:170: 3099-3108.
31. Munroe ME, Arbiser JL, Bishop GA. Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol. 2007;179:753-763.
32. Jalukar SV, Hostager BS, Bishop GA. Characterization of the roles of TRAF6 in CD40-mediated B lymphocyte effector functions. J Immunol. 2000; 164:623-630.
33. Kishimoto T lnterleukin-6: from basic science to medicine-40 years in immunology. Annu Rev Immunol. 2005;23:1-21.
34. Wagner M, Poeck H, Jahrsdoerfer B, et al. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol. 2004;172:954-963.
35. Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007;220:251-269.
36. Rieckmann P, D'Allessandro F, Nordan RP, Fauci AS, Kehrl JH. IL-6 and TNF-a. Autocrine and paracrine cytokines involved in B cell function. J Immunol. 1991;146:3462-3468.
37. Bishop GA, Ramirez LM, Baccam M, Busch LK, Pederson LK, Tomai MA. The immune response modifier, Resiquimod, mimics CD40-induced B cell activation. Cell Immunol. 2001;208:9-17.
38. Bishop GA. Hsing Y, Hostager BS. Jalukar SV, Ramirez LM, Tomai MA. Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848. J Immunol. 2000;165: 5552-5557.
39. Manning E, Pullen SS, Souza DJ, Kehry M, Noelle RJ. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent. Eur J Immunol. 2002;32:39-49.
40. Cavalli-Sforza LL, Menozzi P, Piazza A. The History and Geography of Human Genes. Princeton: Princeton University Press; 1994.
41. Sabeti PC, Reich DE, Higgins JM. et al. Detecting recent positive selection in the human genome from haplotype structure. Nature. 2002;419:832-837.
42. Habib M, Rivas MN, Chamekh M, et al. Cutting edge: small molecule C D40 ligand mimetics promote control of parasitemia and enhance T cells producing IFN-gamma during experimental Trypanosoma cruzi infection. J Immunol. 2007: 178:6700-6704.
43. Kollias G. TNF pathophysiology in murine models of chronic inflammation and autoimmunity. Semin Arthritis Rheum. 2005:34:3-6.
44. Phan TG, Amesbury M, Gardam S, et al. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic selfreactive B cells. J Exp Med. 2003;197:845-860.
45. Benson RA, Hostager BS, Bishop GA. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TRAF6 and PI3K. Eur J Immunol. 2006;36:2535-2543.
46. Hanissian SH, Geha RS. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity. 1997;6:379-388.
47. Jabara HH, Laouini D, Tsitsikov E, et al. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated Ig class switching. Immunity. 2002;17:265-276.
48. Jego G, Pascual V, Palucka AK, Banchereau J. Dendritic cells control B cell growth and differentiation. Curr DirAutoimmun. 2005:8:124-139.
49. Fernandez M, Alarcon GS, Calvo-Alen J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007;57:576-584.
50. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005:21:263-265.